La Jolla, CA, United States of America

Yacov Koffler

This inventor holds 1 USPTO granted patent and 2 published patent applications and 2 EPO patents. Top assignee: University of California. Active years: 2025.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Biomimetic Implants by Yacov Koffler

Introduction

Yacov Koffler is an innovative inventor based in La Jolla, California. He has made significant contributions to the field of biomedical engineering, particularly in the development of implantable devices for treating spinal cord and peripheral nerve injuries. His work focuses on creating solutions that mimic biological processes to enhance healing and recovery.

Latest Patents

Koffler holds a patent for biomimetic implants, which are designed to address spinal cord and peripheral nerve injuries. The patent describes implantable devices that feature a three-dimensional printed structure containing stem cells. These implants are intended to facilitate the treatment of neuronal injuries, providing a promising avenue for recovery.

Career Highlights

Yacov Koffler is affiliated with the University of California, where he conducts research and develops innovative medical technologies. His work has garnered attention for its potential to revolutionize treatments for nerve injuries, making significant strides in the field of regenerative medicine.

Collaborations

Koffler collaborates with notable colleagues such as Shaochen Chen and Mark Henry Tuszynski. Their combined expertise contributes to advancing research in biomimetic technologies and enhancing the effectiveness of medical implants.

Conclusion

Yacov Koffler's contributions to the field of biomimetic implants represent a significant advancement in medical technology. His innovative approach to treating nerve injuries through the use of stem cell-integrated devices holds great promise for future applications in regenerative medicine.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…